metaLead Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.21M

  • Investors
  • 7

metaLead General Information

Description

Developer of peptide-based therapeutics designed to treat metal-related diseases and toxic metal accumulation disorders. The company develops selective metal-binding therapies and chelation treatments for conditions such as Wilson disease and lead poisoning, enabling healthcare providers to remove toxic metals while preserving essential metals and improving patient outcomes.

Contact Information

Website
www.metalead.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Hochbergerstrasse 60C
  • 4057 Basel
  • Switzerland

metaLead Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

metaLead Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 18-May-2025 $1.21M Completed Pre-Clinical Trials
8. Accelerator/Incubator 03-Dec-2024 Completed Pre-Clinical Trials
7. Accelerator/Incubator 01-Oct-2024 Completed Pre-Clinical Trials
6. Accelerator/Incubator 31-Aug-2023 Completed Pre-Clinical Trials
5. Accelerator/Incubator 10-Mar-2023 Completed Pre-Clinical Trials
4. Grant 01-Jan-2023 Completed Pre-Clinical Trials
3. Seed Round 15-Feb-2023 Completed Pre-Clinical Trials
2. Grant 10-May-2022 $10.4K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2022 Completed Pre-Clinical Trials
To view metaLead’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

metaLead Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

metaLead Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
UZH Lifesciences Fund Venture Capital Minority
Kickfund Venture Capital Minority
BaseLaunch Accelerator/Incubator
BioInnovation Institute Accelerator/Incubator
Venture (Switzerland) Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

metaLead FAQs

  • When was metaLead founded?

    metaLead was founded in 2022.

  • Where is metaLead headquartered?

    metaLead is headquartered in Basel, Switzerland.

  • What is the size of metaLead?

    metaLead has 5 total employees.

  • What industry is metaLead in?

    metaLead’s primary industry is Drug Discovery.

  • Is metaLead a private or public company?

    metaLead is a Private company.

  • What is metaLead’s current revenue?

    The current revenue for metaLead is .

  • How much funding has metaLead raised over time?

    metaLead has raised $3.02M.

  • Who are metaLead’s investors?

    UZH Lifesciences Fund, Kickfund, BaseLaunch, BioInnovation Institute, and Venture (Switzerland) are 5 of 7 investors who have invested in metaLead.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process